Mark Anthony Mc Camish is Director of AVADEL PHARMACEUTICALS PLC. Currently has a direct ownership of 11,000 shares of AVDL, which is worth approximately $113,410. The most recent transaction as insider was on Jul 30, 2024, when has been sold 11,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11K
0% 3M change
n/a 12M change
Total Value Held $113,410

Mark Anthony McCamish Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 30 2024
BUY
Grant, award, or other acquisition
-
11,000 Added 50.0%
11,000 Ordinary Shares

Also insider at

VINC
Vincerx Pharma, Inc. Healthcare
RFL
Rafael Holdings, Inc. Real Estate
MAM

Mark Anthony Mc Camish

Director
Dublin 2, L2

Track Institutional and Insider Activities on AVDL

Follow AVADEL PHARMACEUTICALS PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVDL shares.

Notify only if

Insider Trading

Get notified when an Avadel Pharmaceuticals PLC insider buys or sells AVDL shares.

Notify only if

News

Receive news related to AVADEL PHARMACEUTICALS PLC

Track Activities on AVDL